What do early data from Utah’s Doctronic AI pilot show?
Utah has released early data from its pilot program using Doctronic's AI chatbot for prescription renewals. The AI successfully renewed prescriptions 72% of the time, with a high agreement rate among physicians on AI decisions. However, concerns remain regarding the oversight and safety of AI in healthcare, emphasizing the need for independent evaluations.
- ▪The pilot program allows Doctronic to use an AI chatbot to renew prescriptions for about 200 medications.
- ▪The AI renewed prescriptions 72% of the time without needing to escalate to a physician.
- ▪Concerns have been raised about the legality and safety of AI in prescription renewals without FDA authorization.
Opening excerpt (first ~120 words) tap to expand
NewsletterHealth Tech Newsletter What do early data from Utah’s Doctronic AI pilot show? You’re reading the web edition of STAT’s Health Tech newsletter Manage alerts for this article Email this article Share this article Adobe By Mario AguilarMay 26, 2026 Health Tech Correspondent Mario Aguilar[email protected]Mario covers technology in health care, including FDA regulation of artificial intelligence; how Medicare pays for health tech; the use of AI in clinical care; mental health chatbots; and consumer wearables. He’s also the co-author of the free, twice weekly STAT Health Tech newsletter. You can reach Mario on Signal at mariojoze.13. You’re reading the web edition of STAT’s Health Tech newsletter, our guide to how technology is transforming the life sciences.
…
Excerpt limited to ~120 words for fair-use compliance. The full article is at STAT News.
Discussion
0 commentsMore from STAT News
